Passive Equities

First Trust Nasdaq Pharmaceuticals ETF

The First Trust Nasdaq Pharmaceuticals ETF (the “Fund”) seeks investment results that correspond generally to the price and yield (before the Fund’s fees and expenses) of an equity index called the Nasdaq US Smart PharmaceuticalsTM Index (the “Index”).

$26.22

-1.7% last 12 months

Compare similar ETFs

Fund Size
Dividend
Fees
Current
Nasdaq Pharmaceuticals ETF FTXH
Fund Size
$18.7 Million
Dividend
1.5%
Fees
0.60%
Total Stock Market Index Fund VTI
Fund Size
$1.46 Trillion
Dividend
1.4%
Fees
0.03%
500 Index Fund VOO
Fund Size
$982 Billion
Dividend
1.4%
Fees
0.03%
Total International Stock Index Fund VXUS
Fund Size
$404 Billion
Dividend
3.4%
Fees
0.07%
Core S&P 500 ETF IVV
Fund Size
$402 Billion
Dividend
1.4%
Fees
0.03%
View 1287 similar ETFs →

Average metrics of all companies in portfolio

Compare to
Market
Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $138 Billion
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. 2.01 %
Beta Indicates the relationship between the price performance of a share and the market. 0.5072
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 114.04
Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything -39.11
Profitable Companies 87
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 206.41
Price to Sales Ratio Market cap divided by the revenue in the most recent year. 5.33
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 9.38
Compare to
Market
Enterprise Value to EBIT Enterprise Value divided by EBIT 27.15
Enterprise Value to Revenue Enterprise value divided by revenue 11.34
Total Debt to Enterprise Value Total debt divided by enterprise value 0.19
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. -0.4155
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. -65.82%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. -
Return on Equity Equity divided by market cap. -1.58%
Return on Assets Indicates a company's profitability in relation to its total assets. 6.09%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. 11.49%

Industries

Healthcare 92.0%
Other 4.0%
Finance 2.0%
Industrials 2.0%
N/A 0.0%

Market cap

Micro Cap 1%
Small Cap 2%
Mid Cap 16%
Large Cap 56%
Mega Cap 26%

50 Investments

P/E-Ratio
Total Investment
Weight
AbbVie Inc logo

ABBV - Manufacturing

AbbVie Inc

P/E-Ratio
60.5
Total Investment
$1.42 Million
Weight
7.6%
Merck & Co Inc logo

MRK - Manufacturing

Merck & Co Inc

P/E-Ratio
869.1
Total Investment
$1.34 Million
Weight
7.2%
Johnson & Johnson logo

JNJ - Manufacturing

Johnson & Johnson

P/E-Ratio
10.0
Total Investment
$1.3 Million
Weight
7.0%
Bristol-Myers Squibb Co logo

BMY - Manufacturing

Bristol-Myers Squibb Co

P/E-Ratio
12.4
Total Investment
$1.12 Million
Weight
6.0%
Pfizer Inc logo

PFE - Manufacturing

Pfizer Inc

P/E-Ratio
67.9
Total Investment
$1.09 Million
Weight
5.9%
Vertex Pharmaceuticals Inc logo

VRTX - Manufacturing

Vertex Pharmaceuticals Inc

P/E-Ratio
28.1
Total Investment
$784 Thousand
Weight
4.2%
Cardinal Health Inc logo

CAH - Wholesale Trade

Cardinal Health Inc

P/E-Ratio
40.3
Total Investment
$775 Thousand
Weight
4.2%
Amgen Inc logo

AMGN - Manufacturing

Amgen Inc

P/E-Ratio
21.0
Total Investment
$755 Thousand
Weight
4.0%
Regeneron Pharmaceuticals Inc logo

REGN - Manufacturing

Regeneron Pharmaceuticals Inc

P/E-Ratio
24.4
Total Investment
$714 Thousand
Weight
3.8%
Gilead Sciences Inc logo

GILD - Manufacturing

Gilead Sciences Inc

P/E-Ratio
14.5
Total Investment
$712 Thousand
Weight
3.8%
Eli Lilly & Co logo

LLY - Manufacturing

Eli Lilly & Co

P/E-Ratio
135.3
Total Investment
$706 Thousand
Weight
3.8%
Zoetis Inc logo

ZTS - Manufacturing

Zoetis Inc

P/E-Ratio
29.9
Total Investment
$696 Thousand
Weight
3.7%
Viatris Inc logo

VTRS - Finance and Insurance

Viatris Inc

P/E-Ratio
243.9
Total Investment
$677 Thousand
Weight
3.6%
Biogen Inc logo

BIIB - Manufacturing

Biogen Inc

P/E-Ratio
23.9
Total Investment
$651 Thousand
Weight
3.5%
Jazz Pharmaceuticals PLC logo

JAZZ - Manufacturing

Jazz Pharmaceuticals PLC

P/E-Ratio
16.6
Total Investment
$576 Thousand
Weight
3.1%
United Therapeutics Corp logo

UTHR - Manufacturing

United Therapeutics Corp

P/E-Ratio
11.3
Total Investment
$550 Thousand
Weight
2.9%
Charles River Laboratories Int logo

CRL - Professional, Scientific, and Technical Services

Charles River Laboratories Int

P/E-Ratio
24.7
Total Investment
$456 Thousand
Weight
2.4%
Incyte Corp logo

INCY - Professional, Scientific, and Technical Services

Incyte Corp

P/E-Ratio
19.8
Total Investment
$402 Thousand
Weight
2.2%
Medpace Holdings Inc logo

MEDP - Professional, Scientific, and Technical Services

Medpace Holdings Inc

P/E-Ratio
41.0
Total Investment
$321 Thousand
Weight
1.7%
Organon & Co logo

OGN - Manufacturing

Organon & Co

P/E-Ratio
4.5
Total Investment
$298 Thousand
Weight
1.6%
Exelixis Inc logo

EXEL - Professional, Scientific, and Technical Services

Exelixis Inc

P/E-Ratio
32.8
Total Investment
$228 Thousand
Weight
1.2%
Halozyme Therapeutics Inc logo

HALO - Manufacturing

Halozyme Therapeutics Inc

P/E-Ratio
17.1
Total Investment
$181 Thousand
Weight
1.0%
ImmunoGen Inc logo

IMGN - Manufacturing

ImmunoGen Inc

P/E-Ratio
0.0
Total Investment
$176 Thousand
Weight
0.9%
Perrigo Co PLC logo

PRGO - Manufacturing

Perrigo Co PLC

P/E-Ratio
-319.5
Total Investment
$172 Thousand
Weight
0.9%
Prestige Consumer Healthcare I logo

PBH - Manufacturing

Prestige Consumer Healthcare I

P/E-Ratio
-42.1
Total Investment
$156 Thousand
Weight
0.8%